AstraZeneca partners with health startup Docon to digitise 1,000 clinics across India

AstraZeneca partners with health startup Docon to digitise 1,000 clinics across India

FPJ Web DeskUpdated: Wednesday, June 30, 2021, 03:32 PM IST
article-image

Biopharmaceutical company AstraZeneca India (AstraZeneca Pharma India Limited) on Wednesday announced that it has signed a memorandum of understanding with Bengaluru-based health startup, Docon Technologies, for digitising 1,000 clinics across India.

Under the partnership, Docon will equip the identified clinics with customised Electronic Medical Record (EMR) systems enabling clinicians to access complete patient history, a joint statement said.

Gagandeep Singh, Managing Director, AstraZeneca India said, “As a part of AstraZeneca’s continued vision to tackle NCD’s at the grassroot level, we are happy to partner with Docon to develop and provide a sustainable way to prevent, identify and manage NCD’s across the country.”

Akash Valia, Business & Growth Head at Docon Technologies, said "Technology is the key catalyst to reach every corner of India and improve healthcare in the country."

"This will go a long way in helping the clinical community better treat chronic patients and manage long-term complications of non-communicable diseases (NCDs) like diabetes and cardiovascular diseases'', a press statement said.

Towards reaching the 1,000 clinics goal in 2021, on-ground identification and support has been placed in 30 cities.

Till now, as a part of the pilot phase, around 200 clinics have been upgraded with many of them being in Tier 1 & 2 towns, the statement said. In addition to providing the clinicians with a three day in-clinic training for learning and adoption, a dedicated helpline is also being established for the users to understand and resolve technical queries, it was stated.

RECENT STORIES

Rama Steel Tubes Board Approves ₹500 Crore Further Public Offering; Stock Closes Over 6% In Green

Rama Steel Tubes Board Approves ₹500 Crore Further Public Offering; Stock Closes Over 6% In Green

Global NCAP Crash Test: Kia Carens Achieves 3-Star Safety Rating

Global NCAP Crash Test: Kia Carens Achieves 3-Star Safety Rating

RBI Holds Off Countercyclical Capital Buffer Activation

RBI Holds Off Countercyclical Capital Buffer Activation

NBCC Secures New Order Worth ₹23,500 Cr In FY24; Shares Surge Over 7%

NBCC Secures New Order Worth ₹23,500 Cr In FY24; Shares Surge Over 7%

Mahindra Bolero Neo: Only 1-Star Safety Rating in Global NCAP Crash Test

Mahindra Bolero Neo: Only 1-Star Safety Rating in Global NCAP Crash Test